Abstract
e144 PO-111 Appraisal of IgM Kappa/IgM Lambda variations using HevyLite after rituximab as consolidation therapy in patients with Waldenstrom’s Macroglobulinemia J.R. Eveillard, A. Achour, F. N’Go Sack, A. Tempescul, R. Le Calloc’h, A. Dagorne, B. Bendaoud, C. Berthou, S. Hillion, Y. Renaudineau Departement of Clinical Hematology, Brest University Hospital, Brest, France; Laboratory of Immunology and Immunotherapy, Brest University Hospital, Brest, France
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
